#pc: Astella

[decapod-appreciator]

sillyass lil emotes of my dnd group… the 5 pcs + the two favorite npcs

[bhushans]

Bridging the Gap: How the Global Pelvic Cancer Induced Hemorrhagic Cystitis Market is Expanding Access to Care

The global pelvic cancer induced hemorrhagic cystitis market is anticipated to grow to an incredible US$11 billion by 2033. This shows a remarkable growth trajectory from the US$2.1 billion in 2023, with a noteworthy compound annual growth rate (CAGR) of 18.01%.

One potentially devastating adverse effect of pelvic cancer treatment is PC-HC. It results in painful bladder bleeding and inflammation. With the rise of pelvic malignancies, especially endometrial and cervical cancers, there is a critical need for effective PC-HC therapeutic alternatives.

Bladder inflammation and bleeding are symptoms of hemorrhagic cystitis, a debilitating condition. It can happen as a side effect of various treatments for pelvic cancer, including chemotherapy and radiation therapy. The primary drivers of the market expansion are the growing prevalence of pelvic cancer and the growing understanding of hemorrhagic cystitis.

Demand in the industry is being driven by a sustained trend toward unhealthy diets and sedentary lifestyles, as well as growing public awareness of the benefits of early detection and treatment for linked disorders. Physicians can now inject medications directly into sick tissues without endangering nearby healthy cells, thanks to advancements in drug research. As a result, there has been an increase in patient compliance, which is anticipated to facilitate market expansion.

Obtain Your Sample Report Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-16245

The high research and development cost associated with the manufacturing of hemorrahagic cystitis treatment drugs, coupled with increased penetration of generic drugs, is likely to restrain market growth. However, technological advancements in drug development to manufacturing cost-effective and side-effect-free drugs are anticipated to create opportunities for industry movements. Moreover, the use of High approval rate of Ifosfamide and cyclophosphamide for use in a variety of malignancies, both in children and adults are driving the market for Haemorrhagic Cystitis. North America dominates the market for Pelvic Cancer induced Hemorrhagic Cystitis with market valuation of US$ 3.6 Billion, followed by APAC.

Key Takeaways

North American Pelvic cancer induced hemorrhegic cystitis market is expected to reach US$ 3.6 Billion with a CAGR of 14.87% during the forecast period.

With a CAGR of 15.1%, APAC is projected to be fastest growing market for this haemorrhagic cystitis.

By treatment type, chemotherapy is expected to dominate the market with a 2/3rd segment share.

Radiation therapy is anticipated to be a secondary treatment for hemorrhegic cystitis after Chemotherapy.

High cost of treatments and side-effects in post-treatment period will restrict market growth.

Adoption of combination therapies and novel therapies are expected to proliferate product demand.

Technological advancements in drug development for treatment of pelvic induced hemorrhagic cystitis is anticipated to strengthen market footprint.

Customization Available: https://www.futuremarketinsights.com/customization-available/REP-GB-16245

Competitive Landscape

Key players in the Pelvic cancer induced hemorrhagic Cystitis Market are: Johnson & Johnson Services, Inc, Astellas Pharma Inc, Eli Lilly and Company, Sanofi, Ipsen Pharma, Bayer AG, AstraZeneca, Valeant Pharmaceuticals International, Inc., Merck & Co., Inc., Pfizer Inc.

In April 2022, Pfizer made an equity investment worth USD 25 million in Zentalis Pharmaceuticals, Inc. This investment is expected to help Pfizer to leverage its development capabilities globally

In May 2022, Pfizer entered a research collaboration agreement of two years with NetVation DL Medicine. This collaboration is anticipated to aid and advance Pfizer in its research activities

In June 2022, Roche introduced a human papillomavirus (HPV) self-sampling solution that enables patients to perform HPV screening in the presence of a healthcare worker. This is expected to expand the company’s cancer screening solution line-up

In June 2022, Valencia Technologies Corporation announced the implantable neuromodulation technology product eCoin®, which is reshaping the delivery of long-term therapy for bladder control, is a tibial implant for Urge Urinary Incontinence (UUI). eCoin® received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) in March 2022, making it the first and only FDA-approved implantable tibial neurostimulator indicated for the treatment of urge urinary incontinence (UUI). This new product has helped the company to increase its portfolio.

More Valuable Insights 

Future Market Insights, in its new offering, presents an unbiased analysis of the Bullous Keratopathy market, presenting historical analysis from 2017 to 2022 and forecast statistics for the period of 2023 to 2033.

Key Segments Profiled in the Pelvic Cancer Induced Hemorrhagic Cystitis Market Industry Survey

By Treatment:

Bone Marrow Transplant

Chemotherapy

Cyclophosphamide

Ifosfamide

Radiation Therapy

Other Treatments

By Region:

North America

Latin America

Europe

Asia Pacific

Middle East & Africa (MEA)

[americanmysticom]

58 BILLION DOLLARS ANNUAL BUDGET, AND NO VALID STUDY ON NATURAL IMMUNITY?

YET, WITH THE MOST IMPORTANT STUDY COMING OUT OF ISRAEL

Demonstrating 27 Times! Increased Immunity against COVID-19 with Natural Exposure, over the poor effectiveness of the MRNA Booster

“THEY [THE CDC] ARE UNDERMINING NATURAL IMMUNITY STUDIES”

“THEIR [CDC] STUDY WOULDN’T QUALIFY FOR A SEVENTH-GRADE SCIENCE FAIR”

[Can you call the booster effective at all?]

Jim Jordan Urges CDC To Do A Natural Immunity Study And Compare It To The Vaccine Dec 19, 2021

The Hill

Tuesday, a Select Subcommittee on the Coronavirus Crisis held a remote hearing examining the urgent need to accelerate global coronavirus vaccination efforts and the critical role that these efforts play in the nation’s public health and economic recovery.

Congressman Jim Jordan expressed his desire for CDC to use some of its funding to figure out how effective natural immunity is as an alternative to a vaccine.

https://www.youtube.com/watch?v=lJE7Tc8YGsc

https://www.cdcfoundation.org/partner-list/corporations Abbott Ireland Abbott Laboratories 360 thinc, ltd. 3M 3M Pharmaceuticals AB Biodisk Abbott Laboratories AbbVie Inc. Academic Press Accenture ACE Construction Group Acme Cargo Express Singapore ActionSprout Adis International Adobe Advanstar Communications, Inc. Advantage Healthcare, Inc. Aetna, Inc. Affimedix, Inc. AFLAC AG Communications, LLC Agilent Technologies AGL Networks LLC AGL Resources, Inc. AirTran Airways AkzoNobel N.V. Alaska Center for Pediatrics Alere North America, Inc. Allergan, Plc AlphaGraphics Alston + Bird, LLP The American Academy of Allergy, Asthma & Immunology American Petroleum Institute Amgen Inc. The Analytica Group Analytic Services Inc. Annar Diagnostica Anthem Blue Cross and Blue Shield Anthem, Inc. Apatel.com, Inc. Appalachian Power Applied BioCode, Inc. Applied Biosystems Arch Chemicals, Inc. Ark Sciences, Inc. Arrowsmith Consulting, LLC Ascend Media ASI Holdings Inc. Astellas Pharma US, Inc. Astra Merck, Inc. AstraZeneca PLC AT&T Corp. AT&T Georgia Atkinson & Associates, LLC Atlanta Coca-Cola Bottling Company The Atlanta Journal Constitution Atlanta Magazine Autodesk, Inc. Aventis Pasteur Aventis Pasteur Limited Aventis Pharmaceuticals AVNET Inc The Bank of Commerce Barlovento LLC BASF Corporation Batavia Biosciences Bavarian Nordic, Inc. Baxter International Inc. Bayer AG Bayer Corporation Bayer U.S. LLC BD (Becton, Dickinson and Company) BearingPoint, Inc. Beckman Coulter, Inc. BellSouth Corporation BellSouth Telecommunications, LLC Bethpage Federal Credit Union Bijur Lubricating Corporation bioCSL Biogen MA Inc. Biohit Laboratory Services bioMerieux, sa BioPort Corporation Bio-Rad Laboratories, Inc. BioReference Laboratories, Inc. BioTechnical Communications, Inc. Blackwell Science Ltd. BMH Holdings LLC Boditech Med Inc. Boehringer Ingelheim USA Corporation Boehringer Mannheim Corporation Bond, Schoeneck & King, PLLC Boopies Gifts Booz Allen Hamilton Inc. Boston Field & Focus, Inc. Brakeley Briscoe, Inc. Branford Festival Corporation Bristol-Myers Squibb Company Browning-Ferris Industries, Inc. Bunge Limited Byotrol Inc. Cambridge University Press Cargill, Inc. Caribbean Travel Medicine Clinic Celanese Celerant Consulting, Inc. Centocor Ortho Biotech, Inc. Century 21 Today Cepheid Cerilliant Corporation The Charles Schwab Corporation Chem-Aquascience, Inc. Chemux Bioscience, Inc. Chesapeake Surveys Chiron Corporation Chromesystems Instruments & Chemicals GmbH CIBA Vision Corporation CIBC World Markets Corporation Cisco Systems, Inc. Citi Clarivate Analytics Clinical Care Options Clinical Pathology Laboratories, Inc. The Clorox Company CNN/Time Warner The Coca-Cola Company Columbia Management Columbus Auto Body Works, Inc Commonwealth Radiology, PC ConocoPhillips Company Consensus Communications, Inc Contello Towers III, Inc. Contemporary Forums Cook Insurance Agency, Inc. Cooney Waters Group, Inc. Cortlandt Communications, Inc. Costco Covance Covance Market Access Service Coventry Health Care of Georgia Covidien Coxe Curry & Associates, Inc. Craft Technologies, Inc. Crawford Media Services, Inc. CRC Industries, Inc. CSIRO Livestock Industries Cubist Pharmaceuticals, Inc. Cummins Inc. Current Drugs Ltd. Current Medicine Group, LLC Custom Ink Custom Packaging Services, Inc. CVR Associates, Inc. CVS/caremark Annual Giving Campaign CYTYC Corporation D.A. Hughes & Associates D.H. Griffin Companies Dade MicroScan Inc. Daiichi Pharmaceutical Company, Ltd. Darren's Designs Data Management Processing, Inc. David Vance & Associates, Inc. DaVita Mission Viejo Decision Resources, Inc. Dell Inc. Deloitte Consulting LLP Deloitte Services LP Delta Air Lines, Inc. Delta Development Group, Inc. Delta Staffing Services, Inc. Devlin Properties LLC Devries Public Relations DEY, L.P. Diagnostics Biochem Canada Inc. Dialysis Clinic, Inc. DiaSorin Inc. DIAsource Immunoassays Diazyme Laboratories Disney Worldwide Services, Inc. Dodge & Cox Funds DSM Nutritional Products, Inc. DST Systems, Inc. E.T. Enterprises Eastern Mountain Sports Eastman Kodak Company Easton Associates LLC Eastview Veterinary Clinic, P.C. Ecolab Edelman Educational Management Group EIS, Inc Eli Lilly and Company Elsevier Inc. Emergent BioSolutions Inc. Endocrine Sciences Inc. Entertainment Media Ventures Environmental Disciplines, Inc Environmental Systems Research Institute, Inc ESA Biosciences, Inc. Esoterix, Inc ESSRX Eurofins Biomnis Eventbrite Evercore Partners Services East LLC Exel Inc. Exponent ExxonMobil Facebook Fallon Medica LLC FanBox The Father's Love Consulting and Investment Services Inc. Ferraiuoli LLC Fidelity Investments Fleishman-Hillard, Inc. FMC Technologies, Inc. Ford Motor Company Four Seasons Environmental, Inc The Frankel Group, Inc. Fujirebio Diagnostics, Inc Fujirebio Inc. Future Drugs, LTD Ganister Fields Architects GDF Suez Energy North America, Inc. GE Aviation GE Energy GE Medical Systems Genentech, Inc. General Electric Company General Mills, Inc. General Motors Corporation Gen-Probe, Incorporated Genzyme Corporation Georgia Power Georgia-Pacific Corporation Georgia-Pacific Professional GF Health Products, Inc. Gilead Sciences, Inc. GlaxoSmithKline Biologicals S.A. Global, Inc. Global Blood Therapeutics, Inc. Global Good Fund I LLC. GOJO Industries, Inc. Google Inc. Granotec Chile S.A. Greenberg Traurig, LLP Gustav Heningburg Associates, Inc. H & H Consulting Partners, LLC H.B. Sherman Trap, Inc. Hager Companies Hamad Medical Corporation Hampton Inn Hotel Harold's Printing Company Harris Teeter Haymarket Media, Inc. Haymarket Medical HCA, Inc. Health Advances LLC Health Education Technologies Healthcare Performance Consulting, Inc. Healthcomp, Inc. Heartland Assays LLC Henry Schein, Inc. Hexagon Nutrition Pvt. Ltd. Hilton Hotels Corporation Hoffmann-La Roche Inc. Hogan Lovells US LLP Holder Construction Company Holland America Line Hologic Inc. The Home Depot Horizon Communications Horizon Properties Corporation IASIS Healthcare IBM Corporation IBM Employee Services Center ICN Pharmaceuticals Inc. Idenix Pharmaceuticals Ihc Health Services Inc IISES, LLC Image Information, Inc. IMC Imedex, Inc. IMG Immundiagnostik AG Immunodiagnostic Sytems Inc. Immunotech S.A.S. Impact Communications, Inc. ImpactRx, Inc. ImQuest BioSciences Incstar Corporation Independent Charities of America Indusco Distribution of America, Inc. Industrial Metal Powders Infectious Disease Consultants PC Integrated Communications Corp. Intellectual Concepts LLC Intellectual Ventures Management, LLC Inter-American Development Bank International Association of Operative Millers International Medical Publishing, Inc. Intervet International B.V. inVentiv Health Clincial Lab Inc. Invitrogen, Life Technologies Iodine Global Network IQ Solutions Jackson Associates, Inc. Jalonso Group Inc. The James W. Down Company, Inc. Janssen Biotech, Inc. Janssen Global Services, LLC Janssen Scientific Affairs, LLC Janssen Therapeutics Jealco International, Inc. (West) John Wiley & Sons, Inc. Johnson & Johnson Johnson & Johnson Pediatric Institute, LLC Johnson & Johnson Pharmaceutical Services, LLC Jones & Askew, LLP Jupitor Corporation USA JVC Professional Products Company JWT Kadmon Pharmaceuticals, LLC Kaiser Permanente Kaiser Permanente Northern California Division of Research Kalik & Associates, Inc. Kedrion Biopharma Inc. Kendall Strategies Kerricook Construction, Inc. Kilmek, Kolodney & Casale, P.C. Kimberly-Clark Corporation King & Spalding LLP KIPHS, Inc. Knoll AG Kohl's Corporation KPMG International Kris International, LLC Laboratory Alliance of Central New York Laboratory Corporation of America Holdings Laburnum Diagnostic Imaging Assoc. LadDawn Land Yacht Harbor of Melbourne Airstream Park Law Offices of Edwin Marger, LLC The Law Offices of Kevin J. McDonough The Leader Publishing Group, Inc. Liberty Mutual Insurance Life Technologies Corporation LigoCyte Pharmaceuticals LinksPoint Linn Energy Lippincott Williams & Wilkins Lipsey Mountain Spring Water Lonza Group Ltd. Luminex Corporation Luminex Molecular Diagnostics, Inc. Lupin Pharmaceuticals, Inc. Lypro Biosciences, Inc. Magellan Biosciences, Inc. MailChimp Mallinckrodt Group Inc. Marc O'Brien Agency, Inc. MarketVision, Inc. McDonald's Corporation The McGraw-Hill Companies McGraw-Hill Education LLC Medentech Ltd. Medical Economics Company, Inc. Medical Information Systems, Inc. The Medical Letter, Inc. Medical Marketing Research International Ltd. Medical Marketing Studies U.S. Inc. MediMedia Managed Markets, L.L.C. Medimmune, Inc. MediTech Media Ltd. MedPanel, Inc. Medrad Inc. Medscape, LLC Mellon Private Wealth Management Members Give Mercer (US) Inc. Merck Merck Partnership for Giving Metro Foods Metro Logics, Inc. MGK Insect Control Solutions Mickey Leland National Urban Air Toxics Research Center Microbide Limited Microgenics Corporation Micromass UK Ltd Microsoft Corporation Milbank, Tweed, Hadley & McCloy LLP Moelis & Company Molnlycke Health Care, LLC Mondrian Investment Partners (U.S.), Inc. Morgan Keegan & Co., Inc. Mo's Pizza Motorola Inc. Murphy-Moore Properties N2 Qualitative Marketing Research NanoEnTek Inc. Nanosphere, Inc. National Football League Navkar bio-chem NDC Health New & Improved, LLC New England American College of Sports Medicine New England Research Institutes, Inc. New York Society of Infectious Diseases, Inc. Nexstar Farmaceutica, S.A. Nike, Inc. North American Vaccine, Inc. Northrop Grumman Corporation Novartis AG Novartis Investments S.A.R.L. Novartis Pharmaceuticals Corporation Novartis Vaccines and Diagnostics, Inc. Novavax, Inc. Novo Nordisk Inc. OCC North America, Inc. Ogilvy & Mather Oliver Wyman OnStar Corporation Onyx Pharmaceuticals, Inc. Opko Diagnostics, LLC OraSure Technologies, Inc. ORAVAX, Inc. Ortho-Clinical Diagnostics Ortho-McNeil Pharmaceutical, Inc. Orvis Atlanta Store Staff Oxford Immunotec Ltd. Oxford University Press USA Oxoid Ltd. P.H. Moore Anesthesia Services, Inc. Paint World, Inc. PAREXEL Medical Marketing Services Pathcon Laboratories Pathology Associates Medical Laboratories Patterson Belknap Webb & Tyler LLP PayPal PD Bros Penn Schoen & Berland Accociates LLC Penn Treaty Kennel Club Perera V. Chiron Corporation PerkinElmer, Inc. Pfizer Inc. PGS Tech Corp. Pharmacia Corporation Pharmavite LLC PHFE Management Solutions PlowShare Group Inc. Porter Novelli PPD Development, LP Practakal LLC Premier, Inc. Preparis Inc. Princeton Media Associates, Inc. P&G Production Transport, Inc. Prospect Associates, Ltd. Proteus On-Demand Facilities Public Health Management Corp. Pursuant QIAGEN Corporation The Quaker Oats Company Qualcomm Qualigen, Inc. Quest Diagnostics Quidel Corporation The Quigley Corporation RADCO Chemical Solutions, Inc. Rasmus Real Estate Group, Inc. RB Health (US) LLC R-Biopharm Inc. Reckitt Benckiser, Inc. Regional Health Services of Howard County Remel Inc. ReproSource Research in Motion Rexall Sundown, Inc. Richard Bowers & Co. Robert Michael Communications, Inc. Roche Diagnostics Corporation Roche Laboratories, Inc. Roche Molecular Systems, Inc. RockTenn Company Rockwell Collins Rogers Medical Education Network (USA) Inc. Rollins, Inc. Run It Up Productions, Inc. S.C. Johnson & Son, Inc. Sacoor Medical Group, Europe Safeway Inc. Sage Publications, Inc. San Diego Gas & Electric Sands Point Nursing Home Sanofi Pasteur, Inc. Sanofi-Aventis Satair USA, Inc. Schering Plough Corporation Science Applications International Corporation Scientific Therapeutics Info., Inc. Scientific-Atlanta, Inc. SCIEX LLC Seaport Global Holdings LLC The Segal Company SerOptix Shaklee Corporation Shalin Financial Services, Inc. Share Your Share, Inc. The Sherwin-Williams Company Shoreview Nursing Home Shure, Incorporated Siemens Energy & Automation, Inc. Siemens Healthcare Diagnostics, Inc. Siemens USA Sikorsky Aircraft Corporation Simon Kucher & Partners Strategy & Marketing Consultants LLC Simon Property Group Skanska USA Building, Inc. Skippy Musket & Co. Slack, Inc. SmithKline Beecham Pharmaceuticals Social & Scientific Systems, Inc. Solutions Solvay Pharmaceuticals, Inc. Sonnenschein Nath & Rosenthal Southeast Research, Inc. Southern Company Southern Company Services, Inc. Spectrum Brands Spirit AeroSystems Springer SBM BV Springer Science+Business Media LLC Sprint SRA International, Inc. St. Elizabeth Healthcare Staples, Inc. Starbucks Corporation Starfish Associates Limited State Farm Insurance Companies Stiefel Laboratories, Inc. The Stormont Companies LLC Stratton Travel Management Subjective-i Research Subterracom Wireless Solutions, LLC Summit Chemical Company SunTrust Bank SunTrust One Pledge Campaign SureWerx USA Inc. Symbol Technologies, Inc. Synageva BioPharma Corp. Synermed Takeda Pharmaceutical Company Limited Takeda Pharmaceuticals U.S.A., Inc. Target Corporation Taylor and Francis Group, LLC Taylor Technology, Inc. Theranos Thermo Fisher Scientific, Inc. ThermoForma, Inc. Thompson, Ventulett, Stainback & Associates, Inc. Thomson Healthcare Inc. Thomson Reuters Thoroughbred Research Group Inc. Tibra Trading America Times Bank Ltd. T-Mobile USA, Inc. TMS BioScience Labs Tosoh Bioscience, Inc. Tosoh Corporation ToucanEd, Inc. Toyota Motor Sales, U.S.A., Inc. Transtria Trellis Bioscience, Inc. Trellis RSV Holdings, Inc. Tricore Reference Laboratories Tri-State Gastroenterology Trojan Brand Condoms True North Communications, Inc. T-Shirt Mojo Turner Broadcasting System, Inc. Turner Construction Company Turner Learning U.S. Magnesium UBS AG Underwriters Laboratories, Inc. United Industries Corporation United Parcel Service Universal Stabilization Technologies, Inc. University Hospital Gent UpToDate, Inc. USF Medical Services Support Corporation USGlobalSat, Inc. Valeant Pharmaceuticals International Ventria Bioscience Verizon Communications Vertex Pharmaceuticals, Incorporated Vestergaard Frandsen SA Victor G. Polizos, M.D., P.C. Vipelderly Limited ViralED, LLC Viropharma Incorporated ViroStat, Inc. Vista Research Visual Education Corporation Visual Response LTD Viva Entertainment, LLC Voxiva Wachtell, Lipton, Rosen & Katz Walgreen Company Walmart Stores, Inc. Waters Corporation Waters Ireland LTD WebMD, LLC Westat Wirthlin Worldwide Wolters Kluwer Health Workday, Inc. World Health Communications, Inc. Wyeth Wyeth Consumer Healthcare Wyeth Global Pharmaceuticals Wyeth Laboratories Wyeth Pharmaceuticals Xcel Energy XCellAssay, LLC YourCause, LLC YRC Worldwide YUM! Brands, Inc. Zeus Scientific, Inc. Zhejiang Disigns Diagnostics Zila Pharmaceuticals, Inc. ZRT Laboratory, LLC Zurich American Insurance Company Merck for Mothers AB SCIEX

see also;

The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health, Audible Audiobook, Unabridged

https://www.amazon.com/Real-Anthony-Fauci-Pharma-Democracy/dp/B09LVYYTJJ/r

https://www.wikihow.com/Give-Audible-Books-As-a-Gift

[Learn about the men who helped move and fund illegal gain-of-function research from the United States to Communist China, and rehearsed the pandemic to trigger a global bureaucratic and autocratic response - based on that ‘research’ and development.]

autocratic

ô″tə-krăt′ĭk

Relating to or being an autocrat.

Tending to impose one's will on others in an insistent or arrogant manner; domineering. synonym:  dictatorial.

Of or pertaining to autocracy or to an autocrat; absolute; holding independent and arbitrary powers of government.

http://www.cirp.org/library/ethics/nuremberg/

https://www.bmj.com/content/313/7070#NUREMBERG

[It would seem that there is more that is not being disclosed surrounding the vaccine, the financial reset, and global governance.

The people expect real leadership to admit to mistakes, admit to rushing a vaccine that is not ready for prime time, admit to the hundreds of thousands of reported deaths, with millions apparently permanently maimed by a vaccine that does not work, and appears by expert opinion - to destroy long-term natural immunity against any form of virus or cancers.

Now, give people full disclosure as to what is in the vaccine, and tell us why you have been pushing autocracy on democracies and peoples who have been sold for decades that they were free.

Media anchors and pundits have become lairs and propagandists, politicians corporate puppets, and corporations, particularly pharma, the source of autocratic ideologies promoting high-tech surveillance and police-state tactics - now enemies of the people.

Corporations have assumed unlimited control over media and political processes once devoted to public service.

Certain corporations (shielding certain individuals by corporate status),

corporations legally given the status of personhood,

have now decided that they might reign as autocrats in the mold of the Third Reich, unchecked

with bureaucracies and media outlets playing the fiddle.]

see also;

Episode 247: THE RISING TIDE The HighWire with Del Bigtree Published  December 23, 2021

https://rumble.com/vrb73e-episode-247-the-rising-tide.html?

https://thehighwire.com/watch/

It’s Time to Get Factsinated

https://thehighwire.com/

see also;

DR SUCHARIT BHAKDI: ORGANS OF DEAD VACCINATED PROVES AUTO IMMUNE ATTACK - 22/12/2021

https://rumble.com/vrdv2d-dr-sucharit-bhakdi-organs-of-dead-vaccinated-proves-auto-immune-attack-2212.html

On COVID vaccines: why they cannot work, and irrefutable evidence of their causative role in deaths after vaccination

https://doctors4covidethics.org/on-covid-vaccines-why-they-cannot-work-and-irrefutable-evidence-of-their-causative-role-in-deaths-after-vaccination/

https://doctors4covidethics.org/blog/

[I pray to G-d that our good parent intercede to preserve his children from all harm related to this attack on health by the idoliters of modern day]

[charlesccastill]

Commercial Brokers Association Announces 2017 Achievement Awards Finalists

Boston– The Commercial Brokers Association (CBA) announced the finalists for its annual CBA Achievement Awards, which will recognize the Greater Boston area’s most significant real estate deals of 2017 and honor local industry professionals who have distinguished themselves among their peers.

At the dinner on March 22, 2018 at the InterContinental Boston, awards will be given in the following categories: Deal of the Year Awards will be presented for Office (Boston, Greater Cambridge and Suburban), Retail, Industrial, Life Science and Most Creative deals, as well as the Investment Sale of the Year; a new President’s Council Award will be unveiled this year, recognizing an exceptional transaction; and Special Recognition Awards will be presented to the Broker, Landlord, Rising Star, and Collaborating Professional of the Year. 

Finalists in each category are as follows:

Deal of the Year:

Office – Boston

Alexion (lease)

Bose Corporation (lease)

DraftKings (lease)

Mintz Levin Cohn Ferris Glovsky & Popeo PC (lease)

PTC Corporation (lease)

Reebok (lease)

  Office – Greater Cambridge

InterSystems Corporation (lease)

  Office – Suburban

Astellas Institute of Regenerative Medicine, Westborough, MA (lease)

Hologic, Inc., Marlborough, MA (lease)

Insulet Corporation, Acton, MA (sale)

iRobot Corporation, Bedford, MA (lease)

Raytheon Company, Woburn, MA (lease)

Straumann Manufacturing, Andover, MA (lease)

Retail

Lynx Fitness Club – Topgolf® Swing Suite, Boston, MA (lease)

Trillium Brewing Company, Boston, MA (lease)

Industrial

66 Saratoga Boulevard, Devens, MA (lease)

Life Science

Agios Pharmaceuticals, Cambridge, MA (lease)

Dana-Farber Cancer Institute, Boston, MA (sale)

Ironwood Pharmaceuticals, Cambridge, MA (lease)

Shire Human Genetic Therapies, Cambridge, MA (lease)

Most Creative Deal Under 100,000 sf

960 Massachusetts Avenue, Boston, MA (sale)

Brattle Court at Harvard Square, Cambridge, MA (sale)

Liberty Travel, Boston, MA (lease)

Mass Innovation Labs, Boston Landing, Boston, MA (lease)

Mass Innovation Labs, iSQ Seaport, Boston, MA (lease)

Optimus Ride, Boston, MA (lease)

Investment Sale

10 St. James Avenue & 75 Arlington Street, Boston, MA

100 Northern Avenue, Boston, MA

Hayden Research Campus, Lexington, MA

Special Recognition Awards:

Broker of the Year Leadership Award

Kristin Blount, Colliers International

Matt Daniels, JLL

Michael Joyce, Cushman & Wakefield

Robert Richards, Cushman & Wakefield

Joe Sciolla, Cresa

Mark Winters, Newmark Knight Frank

Landlord of the Year

A.W. Perry

Atlantic Management

Millennium Partners

National Development

NB Development

Oxford Properties

Rockpoint Group

TH Real Estate

Rising Star of the Year

Jonathan Bryant, Colliers International

Joe Fabiano, JLL

Robert Glor, McCall & Almy

Tyler Hilson, Perry Brokerage Associates

Bobby Jangro, JLL Tyler McGrail, Newmark Knight Frank

Kevin McNamara, Cushman & Wakefield

Matt Perry, Avison Young

Margaret Power, Cushman & Wakefield

Amanda Stevens Snell, The Stevens Group

Collaborating Professional of the Year

Dain, Torpy, Le Ray, Wiest & Garner, P.C.

Fusion Design Consultants, Inc.

Goodwin Procter

VHB

For more information or to register for the CBA Achievement Awards dinner, visit: www.CBAAwards.com.

Founded in 1991, the Commercial Brokers Association represents over 400 members in the commercial brokerage community throughout Massachusetts.  CBA is deeply committed to providing relevant educational programs, promoting professionalism and cooperation, and creating an atmosphere where knowledge and ideas are easily exchanged.

  from boston condos ford realtor http://bostonrealestatetimes.com/commercial-brokers-association-announces-2017-achievement-awards-finalists/

[steffanpark11-blog]

Vaginitis Therapeutics Sales Market Research Report – Global Forecast to 2022

In this report, the global Vaginitis Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Vaginitis Therapeutics for these regions, from 2012 to 2022 (forecast), covering  United States  China  Europe  Japan  Southeast Asia  India

Request PDF Sample of Vaginitis Therapeutics Market Report @ https://martresearch.com/contact/request-sample/2/675

Global Vaginitis Therapeutics market competition by top manufacturers/players, with Vaginitis Therapeutics sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including  Pfizer  Janssen Pharmaceuticals  Abbott Laboratories  GlaxoSmithKline  Sanofi  Novartis  Bayer  Bristol-Myers-Squibb  Eli Lilly  Merck  Astellas Pharma  Enzon Pharmaceuticals  Galderma SA  Gilead Sciences  Medicis Pharmaceutical  Teva Pharmaceutical Industries  Starpharma Holdings

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into  Antifungal Agents  Antibiotics  Hormones

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including  Hospitals  Clinics  Ambulatory Surgical Centers  Specialized Gynecology Centers  Other

Browse the full report @ https://martresearch.com/market-analysis/Global-Vaginitis-Therapeutics-Sales-Market-Report-2017/2/675

Table of Contents

1 Vaginitis Therapeutics Market Overview  1.1 Product Overview and Scope of Vaginitis Therapeutics  1.2 Classification of Vaginitis Therapeutics by Product Category  1.2.1 Global Vaginitis Therapeutics Market Size (Sales) Comparison by Type (2012–2022)  1.2.2 Global Vaginitis Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016  1.2.3 Antifungal Agents  1.2.4 Antibiotics  1.2.5 Hormones  1.3 Global Vaginitis Therapeutics Market by Application/End Users  1.3.1 Global Vaginitis Therapeutics Sales (Volume) and Market Share Comparison by Application (2012–2022)  1.3.2 Hospitals  1.3.3 Clinics  1.3.4 Ambulatory Surgical Centers  1.3.5 Specialized Gynecology Centers  1.3.6 Other  1.4 Global Vaginitis Therapeutics Market by Region  1.4.1 Global Vaginitis Therapeutics Market Size (Value) Comparison by Region (2012–2022)  1.4.2 United States Vaginitis Therapeutics Status and Prospect (2012–2022)  1.4.3 China Vaginitis Therapeutics Status and Prospect (2012–2022)  1.4.4 Europe Vaginitis Therapeutics Status and Prospect (2012–2022)  1.4.5 Japan Vaginitis Therapeutics Status and Prospect (2012–2022)  1.4.6 Southeast Asia Vaginitis Therapeutics Status and Prospect (2012–2022)  1.4.7 India Vaginitis Therapeutics Status and Prospect (2012–2022)  1.5 Global Market Size (Value and Volume) of Vaginitis Therapeutics (2012–2022)  1.5.1 Global Vaginitis Therapeutics Sales and Growth Rate (2012–2022)  1.5.2 Global Vaginitis Therapeutics Revenue and Growth Rate (2012–2022)

2 Global Vaginitis Therapeutics Competition by Players/Suppliers, Type and Application  2.1 Global Vaginitis Therapeutics Market Competition by Players/Suppliers  2.1.1 Global Vaginitis Therapeutics Sales and Market Share of Key Players/Suppliers (2012–2017)  2.1.2 Global Vaginitis Therapeutics Revenue and Share by Players/Suppliers (2012–2017)  2.2 Global Vaginitis Therapeutics (Volume and Value) by Type  2.2.1 Global Vaginitis Therapeutics Sales and Market Share by Type (2012–2017)  2.2.2 Global Vaginitis Therapeutics Revenue and Market Share by Type (2012–2017)  2.3 Global Vaginitis Therapeutics (Volume and Value) by Region  2.3.1 Global Vaginitis Therapeutics Sales and Market Share by Region (2012–2017)  2.3.2 Global Vaginitis Therapeutics Revenue and Market Share by Region (2012–2017)  2.4 Global Vaginitis Therapeutics (Volume) by Application

Read More…

Enquiry before Buying @ https://martresearch.com/contact/enquiry/2/675

About Us

MART RESEARCH value your time the most as we believe that time saved is directly proportional to profits earned. Reports of all major industries ranging from Agriculture to Electronics, Software to Medical Care, Food and Beverages to Construction, etc. are available for sampling and later for purchase. The sample reports provide an impressive insight on the research material which would ascertain our clients take the appropriate decision in quick time. The authenticity of these reports will enable organizations make smart, time-bound and critical decisions on market entry and sizing strategies, market share and competitive analysis, product portfolio and opportunity analysis with utmost ease.

Contact Us

Name: Morris Beck  Email: sales@martresearch.com Organization: Mart Research Address: 5708 Copper Creek Court Charlotte North Carolina 28227, USA Phone: +1–857–300–1122

[lindahoward-blog1]

Fidaxomicin Sales Market – International Marketing Strategy Analysis 2017

Geographically, this report split global into several key Regions, with sales (K Pcs) , revenue (Million USD) , market share and growth rate of Fidaxomicin for these regions, from 2012 to 2022 (forecast) , covering United States China Europe Japan Southeast Asia India

Request a sample of this report @ http://www.reportsweb.com/inquiry&RW0001724998/sample .

Global Fidaxomicin market competition by top manufacturers/players, with Fidaxomicin sales volume, Price (USD/Pcs) , revenue (Million USD) and market share for each manufacturer/player; the top players including Astellas Merck ... On the basis of product, this report displays the sales volume (K Pcs) , revenue (Million USD) , product price (USD/Pcs) , market share and growth rate of each type, primarily split into Purity:90% Purity:95% Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Fidaxomicin for each application, including Hospital Retail Pharmacies

Browse Complete Report @ http://www.reportsweb.com/global-fidaxomicin-sales-market-report-2017 .

Some points from TOC:

Global Fidaxomicin Sales Market Report 2017 1 Fidaxomicin Market Overview 1.1 Product Overview and Scope of Fidaxomicin 1.2 Classification of Fidaxomicin by Product Category 1.2.1 Global Fidaxomicin Market Size (Sales) Comparison by Type (2012-2022) 1.2.2 Global Fidaxomicin Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 Purity:90% 1.2.4 Purity:95% 1.2.5 Others 1.3 Global Fidaxomicin Market by Application/End Users 1.3.1 Global Fidaxomicin Sales (Volume) and Market Share Comparison by Application (2012-2022) 1.3.2 Hospital 1.3.3 Retail Pharmacies 1.4 Global Fidaxomicin Market by Region 1.4.1 Global Fidaxomicin Market Size (Value) Comparison by Region (2012-2022) 1.4.2 United States Fidaxomicin Status and Prospect (2012-2022) 1.4.3 China Fidaxomicin Status and Prospect (2012-2022) 1.4.4 Europe Fidaxomicin Status and Prospect (2012-2022) 1.4.5 Japan Fidaxomicin Status and Prospect (2012-2022) 1.4.6 Southeast Asia Fidaxomicin Status and Prospect (2012-2022) 1.4.7 India Fidaxomicin Status and Prospect (2012-2022) 1.5 Global Market Size (Value and Volume) of Fidaxomicin (2012-2022) 1.5.1 Global Fidaxomicin Sales and Growth Rate (2012-2022) 1.5.2 Global Fidaxomicin Revenue and Growth Rate (2012-2022) 2 Global Fidaxomicin Competition by Players/Suppliers, Type and Application 2.1 Global Fidaxomicin Market Competition by Players/Suppliers 2.1.1 Global Fidaxomicin Sales and Market Share of Key Players/Suppliers (2012-2017) 2.1.2 Global Fidaxomicin Revenue and Share by Players/Suppliers (2012-2017) 2.2 Global Fidaxomicin (Volume and Value) by Type 2.2.1 Global Fidaxomicin Sales and Market Share by Type (2012-2017) 2.2.2 Global Fidaxomicin Revenue and Market Share by Type (2012-2017) 2.3 Global Fidaxomicin (Volume and Value) by Region 2.3.1 Global Fidaxomicin Sales and Market Share by Region (2012-2017) 2.3.2 Global Fidaxomicin Revenue and Market Share by Region (2012-2017) 2.4 Global Fidaxomicin (Volume) by Application

Purchase a copy of this report @ http://www.reportsweb.com/buy&RW0001724998/buy/4000 .

3 United States Fidaxomicin (Volume, Value and Sales Price) 3.1 United States Fidaxomicin Sales and Value (2012-2017) 3.1.1 United States Fidaxomicin Sales and Growth Rate (2012-2017) 3.1.2 United States Fidaxomicin Revenue and Growth Rate (2012-2017) 3.1.3 United States Fidaxomicin Sales Price Trend (2012-2017) 3.2 United States Fidaxomicin Sales Volume and Market Share by Players 3.3 United States Fidaxomicin Sales Volume and Market Share by Type 3.4 United States Fidaxomicin Sales Volume and Market Share by Application

About Us:

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

Contact Information:

Call: +1-646-491-9876

Email: sales@reportsweb.com

[charlesccastill]

Commercial Brokers Association Announces 2017 Achievement Awards Finalists

Boston– The Commercial Brokers Association (CBA) announced the finalists for its annual CBA Achievement Awards, which will recognize the Greater Boston area’s most significant real estate deals of 2017 and honor local industry professionals who have distinguished themselves among their peers.

At the dinner on March 22, 2018 at the InterContinental Boston, awards will be given in the following categories: Deal of the Year Awards will be presented for Office (Boston, Greater Cambridge and Suburban), Retail, Industrial, Life Science and Most Creative deals, as well as the Investment Sale of the Year; a new President’s Council Award will be unveiled this year, recognizing an exceptional transaction; and Special Recognition Awards will be presented to the Broker, Landlord, Rising Star, and Collaborating Professional of the Year. 

Finalists in each category are as follows:

Deal of the Year:

Office – Boston

Alexion (lease)

Bose Corporation (lease)

DraftKings (lease)

Mintz Levin Cohn Ferris Glovsky & Popeo PC (lease)

PTC Corporation (lease)

Reebok (lease)

  Office – Greater Cambridge

InterSystems Corporation (lease)

  Office – Suburban

Astellas Institute of Regenerative Medicine, Westborough, MA (lease)

Hologic, Inc., Marlborough, MA (lease)

Insulet Corporation, Acton, MA (sale)

iRobot Corporation, Bedford, MA (lease)

Raytheon Company, Woburn, MA (lease)

Straumann Manufacturing, Andover, MA (lease)

Retail

Lynx Fitness Club – Topgolf® Swing Suite, Boston, MA (lease)

Trillium Brewing Company, Boston, MA (lease)

Industrial

66 Saratoga Boulevard, Devens, MA (lease)

Life Science

Agios Pharmaceuticals, Cambridge, MA (lease)

Dana-Farber Cancer Institute, Boston, MA (sale)

Ironwood Pharmaceuticals, Cambridge, MA (lease)

Shire Human Genetic Therapies, Cambridge, MA (lease)

Most Creative Deal Under 100,000 sf

960 Massachusetts Avenue, Boston, MA (sale)

Brattle Court at Harvard Square, Cambridge, MA (sale)

Liberty Travel, Boston, MA (lease)

Mass Innovation Labs, Boston Landing, Boston, MA (lease)

Mass Innovation Labs, iSQ Seaport, Boston, MA (lease)

Optimus Ride, Boston, MA (lease)

Investment Sale

10 St. James Avenue & 75 Arlington Street, Boston, MA

100 Northern Avenue, Boston, MA

Hayden Research Campus, Lexington, MA

Special Recognition Awards:

Broker of the Year Leadership Award

Kristin Blount, Colliers International

Matt Daniels, JLL

Michael Joyce, Cushman & Wakefield

Robert Richards, Cushman & Wakefield

Joe Sciolla, Cresa

Mark Winters, Newmark Knight Frank

Landlord of the Year

A.W. Perry

Atlantic Management

Millennium Partners

National Development

NB Development

Oxford Properties

Rockpoint Group

TH Real Estate

Rising Star of the Year

Jonathan Bryant, Colliers International

Joe Fabiano, JLL

Robert Glor, McCall & Almy

Tyler Hilson, Perry Brokerage Associates

Bobby Jangro, JLL Tyler McGrail, Newmark Knight Frank

Kevin McNamara, Cushman & Wakefield

Matt Perry, Avison Young

Margaret Power, Cushman & Wakefield

Amanda Stevens Snell, The Stevens Group

Collaborating Professional of the Year

Dain, Torpy, Le Ray, Wiest & Garner, P.C.

Fusion Design Consultants, Inc.

Goodwin Procter

VHB

For more information or to register for the CBA Achievement Awards dinner, visit: www.CBAAwards.com.

Founded in 1991, the Commercial Brokers Association represents over 400 members in the commercial brokerage community throughout Massachusetts.  CBA is deeply committed to providing relevant educational programs, promoting professionalism and cooperation, and creating an atmosphere where knowledge and ideas are easily exchanged.

  from boston condos ford realtor http://bostonrealestatetimes.com/commercial-brokers-association-announces-2017-achievement-awards-finalists/